Item 1.01. Entry into a Material Definitive Agreement.
On April 12, 2021, Tio Tech A (the “Company”) consummated its initial public offering (“IPO”) of 30,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $300,000,000.
In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-253369) for the IPO, initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on February 22, 2021, as amended (the “Registration Statement”):
| • | | An Underwriting Agreement, dated April 7, 2021, by and between the Company and Deutsche Bank Securities Inc., as representative of the underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference. |
| • | | A Warrant Agreement, dated April 7, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference. |
| • | | A Letter Agreement, dated April 7, 2021 (the “Letter Agreement”), by and among the Company, its executive officers, its directors, its advisors and Lindentor 1055. V V GmbH (to be renamed Tio Tech SPAC Holdings GmbH) (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference. |
| • | | An Investment Management Trust Agreement, dated April 7, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference. |
| • | | A Registration Rights Agreement, dated April 7, 2021, by and between the Company, the Sponsor and the Holders signatory thereto, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference. |
| • | | A Private Placement Warrants Purchase Agreement, dated April 7, 2021, by and between the Company and the Sponsor (the “Private Placement Warrants Purchase Agreement”), a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference. |
| • | | A Services Agreement, dated April 7, 2021, by and among the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference. |
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of 5,083,333 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $7,625,000. The Private Placement Warrants are identical to the Warrants included as part of the Units sold in the IPO, except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A Ordinary Shares issuable upon exercise of the warrants), subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of the Company’s initial business combination, (iii) may be exercised on a cashless basis and (iv) are entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the IPO, on April 7, 2021, Dominik Richter, Roman Kirsch, Manuel Stotz, Jonathan Teklu and Jeronimo Folgueira (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Board has determined that Mr. Stotz, Mr. Teklu, and Mr. Folgueira are independent directors within the meaning of applicable SEC and Nasdaq rules. Effective April 7, 2021, Mr. Stotz, Mr. Teklu and Mr. Folgueira were appointed to the Board’s Audit Committee, with Mr. Folgueira serving as chair of the Audit Committee. Effective April 7, 2021, Mr. Teklu and Mr. Folgueira were appointed to the Board’s Compensation Committee, with Mr. Teklu serving as chair of the Compensation Committee. Effective April 7, 2021, Mr. Stotz, Mr. Teklu and Mr. Folgueira were appointed to the Board’s Nominating and Corporate Governance Committee, with Mr. Stotz serving as chair of the Nominating and Corporate Governance Committee.
Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, consisting of Manuel Stotz, will expire at our first annual general meeting; the term of office of the second class of directors, consisting of Jonathan Teklu and Jeronimo Folgueira, will expire at the second annual general meeting; and the term of office of the third class of directors, consisting of Roman Kirsch and Dominik Richter, will expire at the third annual general meeting.